Vaginal estrogen therapy does not increase the risk for recurrence in women with hormone receptor (HR)–negative breast cancer or in those with HR–positive tumors concurrently treated with tamoxifen ...

Hormone therapy for breast cancer is not the same as hormone replacement therapy at menopause, in which hormones are given to reduce the symptoms that can be associated with menopause.

Hormone therapy may be used by young women to relieve symptoms from hormone-­related conditions, menopause, or gynecologic surgery. Use of estrogen hormone therapy was inversely associated with ...

Unopposed estrogen hormone therapy (E-HT) reduces breast cancer risk, while estrogen plus progestin hormone therapy (EP-HT) increases it, especially with long-term use. The study analyzed data from ...

Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet Oncology. Katie M. O ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. The study, "Hormone therapy use and young ...

Women contemplating hormone replacement therapy to ease hot flashes, night sweats and other miseries of menopause might be ...

Faslodex (fulvestrant) is a prescription medicine used for people with certain types of breast cancer. Faslodex is given as an injection into the buttocks (gluteal area) by a health care provider in a ...

SAN ANTONIO -- Menopausal hormone therapy (MHT) did not increase breast cancer risk in women with BRCA mutations, according to a study reported here. In fact, women who used estrogen-only MHT had a ...

It’s a common misconception that menopausal hormone therapy (MHT) causes breast cancer. But this misconception and others about MHT could be standing between you and relief. You might’ve heard that ...